proteolyt
cleavag
viral
envelop
glycoprotein
receptor
bind
fusogen
transmembran
subunit
import
regul
viru
entri
infect
previou
studi
show
viral
glycoprotein
activ
mediat
secret
proteas
recogn
either
monobas
multibas
cleavag
site
cleavag
viral
glycoprotein
demonstr
retroviru
ortho
paramyxovirus
regul
viru
entri
fusion
extracellular
process
envelop
glycoprotein
major
impact
infect
virul
avirul
strain
influenza
virus
sendai
viru
newcastl
diseas
viru
typic
exampl
influenza
viru
viruscel
fusion
activ
induc
posttransl
proteolyt
cleavag
envelop
glycoprotein
mediat
trypsinlik
proteas
bronchial
epithelium
airway
secret
sever
proteas
tryptas
clara
miniplasmin
ectop
anion
trypsin
mastcel
tryptas
tryptas
isol
airway
epitheli
select
cleav
consensu
cleavag
motif
human
influenza
viru
envelop
glycoprotein
determin
viru
tropism
infect
recent
advanc
human
genom
studi
identifi
larg
number
transmembran
serin
proteas
tmprss
variou
tmprss
member
known
airway
local
identifi
respiratori
tract
one
newli
identifi
member
type
ii
transmembran
serin
proteas
express
upper
respiratori
tract
pharynx
trachea
unpublish
data
howev
less
known
tmprss
activ
pneumotrop
viru
natur
infect
although
enhanc
viru
infect
demonstr
bovin
bcov
rat
rcv
coronavirus
treatment
cell
trypsin
precis
role
trypsin
coronaviru
infect
still
unknown
sever
member
coronaviru
possess
proteas
cleavag
site
essenti
infect
viruscel
membran
fusion
cleavag
site
yield
two
noncoval
link
subunit
ntermin
subunit
respons
receptor
bind
wherea
membraneanchor
subunit
import
fusion
viral
cellular
membran
evid
mous
hepat
viru
mhv
bcov
suggest
import
protein
cleavag
two
noncoval
link
subunit
remain
viru
envelop
surfac
viru
matur
uncleav
protein
function
cleavag
may
enhanc
cell
fusion
activ
andor
viru
infect
suscept
protein
cleavag
depend
viru
strain
host
cell
type
similar
group
coronavirus
sequenc
analysi
suggest
protein
sarscov
expect
cleav
sinc
typic
amino
acid
cleavag
site
found
coronaviru
group
ii
iii
rrfrr
rrsrr
rsrr
rar
rarr
locat
sar
protein
recent
find
suggest
import
trypsin
treatment
activ
sar
spike
glycoprotein
mediat
cellcel
fusion
syncytia
format
observ
sar
spike
glycoprotein
express
cell
cell
brief
trypsin
treatment
trypsin
shown
induc
cleavag
monobas
cleavag
site
activ
influenza
virus
cell
cultur
system
known
whether
function
spike
glycoprotein
depend
activ
trypsin
induc
proteolyt
cleavag
noth
known
role
proteas
cleavemodifi
sar
spike
glycoprotein
natur
infect
conform
reorgan
sar
spike
glycoprotein
demonstr
cryoelectron
microscop
analysi
wherebi
structur
transit
spike
glycoprotein
observ
irradi
sarscov
virion
bind
viru
receptor
angiotensinconvert
enzym
experi
show
receptorbind
subsequ
membran
fusion
occur
differ
phase
structur
rearrang
possibl
proteasemodifi
sar
spike
glycoprotein
de
facto
glycoprotein
respons
viru
entri
address
possibl
investig
whether
cleavag
signific
effect
sarscov
entri
airway
epitheli
cell
use
spseudotyp
lentivir
vector
sarscovpp
encod
luciferas
report
gene
mimic
sarscov
entri
observ
sarscov
spike
glycoprotein
effici
cleav
sever
airway
proteas
process
enhanc
entri
sarscovpp
furthermor
identifi
put
cleavag
site
airway
proteas
sitedirect
mutagenesi
determin
role
specif
amino
acid
residu
proteolyt
process
envelop
glycoprotein
sarscovpp
entri
human
airway
epitheli
cell
vitro
manuscript
still
progress
one
two
natur
cleavag
site
describ
posit
report
separ
independ
studi
use
trypsin
cleavag
studi
support
strengthen
demonstr
critic
role
receptordepend
cleavag
spike
protein
airway
proteas
provid
deeper
insight
exact
mechan
viru
entri
enhanc
respiratori
tract
shown
primari
site
sarscov
entri
order
studi
effect
airway
proteas
sarscov
entri
mechan
suscept
variou
human
airway
epitheli
cell
line
test
sarscov
smediat
infect
monitor
sarscov
entri
pseudotyp
lentivir
vector
sarscov
spike
glycoprotein
refer
herein
sarscovpp
recombin
virus
encod
luciferas
report
gene
express
sarscov
spike
glycoprotein
virion
surfac
shown
faith
mimic
sarscov
entri
process
three
differ
airway
cell
line
analyz
sarscovpp
infect
observ
cell
human
bronchial
epitheli
cell
effici
infect
sarscovpp
level
luciferas
activ
similar
measur
posit
control
cell
line
figur
contrast
anoth
human
bronchial
epitheli
cell
line
human
alveolar
cell
line
nonpermiss
sarscovpp
infect
figur
suscept
sarss
mediat
infect
correl
well
express
inde
detect
rtpcr
cell
figur
result
support
previou
data
show
function
cellular
receptor
sarscov
cell
therefor
chosen
subsequ
proteas
cleavag
studi
suscept
purifi
recombin
trispik
protein
proteas
cleavag
investig
airway
proteas
sarscov
pneumotrop
proteas
cleavag
purifi
trispik
protein
perform
treat
trispik
protein
airway
proteas
follow
amino
acid
sequenc
analys
result
indic
differ
airway
proteas
recogn
amino
acid
residu
spike
cleavag
site
figur
also
observ
addit
band
migrat
kda
may
repres
either
incomplet
cleavag
product
contamin
immunopurifi
trispik
amino
acid
sequenc
correspond
cleav
sar
spike
identifi
sequenc
figur
effici
proteas
cleavag
activ
also
studi
compar
yield
cleavag
product
obtain
hplc
analysi
use
synthet
peptid
correspond
cleav
sar
spike
sequenc
result
show
trypsin
recogn
cleav
peptid
posit
effici
proteas
cleav
peptid
posit
effici
wherea
plasmin
cleav
peptid
posit
effici
data
shown
sequenc
analysi
cleavag
product
show
trypsin
plasmin
proteas
cleav
spike
glycoprotein
posit
figur
interestingli
amino
acid
residu
previous
propos
potenti
cleavag
site
spike
gener
subunit
proteas
process
coronavirus
surfac
glycoprotein
subunit
import
activ
fusion
viral
envelop
cellular
membran
viru
entri
step
cleavag
trypsin
plasmin
proteas
amino
acid
residu
suggest
involv
airway
proteas
viru
entri
fusion
amino
acid
residu
also
sensit
cleavag
trypsin
plasmin
proteas
site
lie
within
subunit
region
could
import
rearrang
possibl
bring
viru
envelop
cellular
membran
close
proxim
facilit
viruscel
fusion
altogeth
identifi
least
two
amino
acid
residu
sensit
airway
proteas
cleavag
vitro
may
import
vivo
viru
entri
fusion
next
investig
effect
airway
proteas
treatment
sarscovpp
entri
human
airway
epitheli
cell
cell
firstli
sarscovpp
pretreat
airway
proteas
incub
cell
observ
proteolyt
cleavag
spike
protein
viru
attach
cell
enhanc
effect
viru
entri
figur
contrari
trypsin
plasmin
treatment
significantli
reduc
infect
sarscovpp
figur
accord
observ
like
proteas
treatment
digest
region
crucial
bind
thu
result
reduc
infect
sarscovpp
sinc
attach
viru
receptor
may
trigger
critic
conform
chang
proteolyt
cleavag
reason
necessari
investig
whether
airway
proteas
would
alter
sarscovpp
entri
viruscel
attach
cell
preincub
sarscovpp
figur
lentivir
vector
without
surfac
glycoprotein
refer
herein
empp
figur
ice
henc
allow
viru
attach
viru
entri
unbound
sarscovpp
empp
wash
away
proteas
ad
condit
airway
proteas
treatment
significantli
enhanc
infect
trispik
pseudotyp
figur
verifi
concentr
airway
proteas
enhanc
effect
viru
entri
unbound
sarscovpp
wash
away
variou
concentr
proteas
ad
enhanc
sarscovpp
entri
increas
higher
concentr
proteas
figur
taken
togeth
observ
clearli
demonstr
airway
proteas
activ
modul
effici
sarscov
entri
human
airway
epitheli
cell
manner
stepdepend
viruscel
attach
multipl
sequenc
align
done
differ
isol
sarscov
spike
glycoprotein
locat
airway
proteas
cleavag
site
figur
clearli
potenti
airway
proteas
cleavag
motif
rel
conserv
variou
isol
sequenc
ident
order
studi
function
role
proteas
cleavag
site
alanin
substitut
either
singl
doubl
mutat
gener
sitedirect
mutagenesi
figur
test
pseudotyp
lentivir
vector
differ
mutant
sarscov
spike
glycoprotein
express
wildtyp
mutant
envelop
protein
transfect
cell
test
western
blot
analysi
figur
cell
lysat
express
spike
show
characterist
doublet
sar
spike
glycoprotein
upper
panel
lane
indic
sar
spike
glycoprotein
express
process
incorpor
high
mannos
complex
sugar
case
mutant
plasmid
express
level
doublet
pattern
sar
spike
glycoprotein
cell
lysat
suggest
envelop
protein
express
posttransl
modif
significantli
affect
substitut
figur
upper
panel
lane
contrast
doubl
mutat
plasmid
exhibit
greatli
reduc
level
complexsugar
link
envelop
express
cell
lysat
without
appar
alter
addit
highmannos
sugar
figur
upper
panel
lane
possibl
doubl
mutat
could
affect
proper
fold
oligomer
import
matur
envelop
glycoprotein
aim
establish
whether
mutant
sar
spike
glycoprotein
effici
incorpor
sarscovpp
western
blot
analysi
pseudotyp
particl
purifi
sucros
cell
transfect
either
wildtyp
mutant
plasmid
proper
virion
incorpor
requir
surfac
express
envelop
glycoprotein
depend
upon
correct
fold
oligomer
shown
figur
assembl
cotransfect
foreign
protein
bona
fide
pseudoparticl
test
presenc
hiv
protein
lentivir
vector
backbon
sampl
wildtyp
pseudotyp
express
envelop
glycoprotein
singl
band
figur
middl
panel
lane
suggest
envelop
glycoprotein
incorpor
pseudotyp
detect
complexsugar
highmannos
link
envelop
purifi
pseudotyp
indic
envelop
glycoprotein
incorpor
requir
complet
qualitycontrol
process
along
secretori
pathway
contrast
doubl
mutant
exhibit
complet
lack
pseudotyp
incorpor
envelop
glycoprotein
figur
middl
panel
lane
illustr
presenc
absenc
matur
envelop
glycoprotein
figur
lower
panel
lane
surprisingli
singl
mutant
exhibit
differenti
pattern
envelop
glycoprotein
incorpor
pseudotyp
figur
middl
panel
lane
construct
display
band
pattern
similar
wildtyp
suggest
envelop
glycoprotein
express
transfect
cell
howev
detect
purifi
pseudotyp
absenc
envelop
glycoprotein
incorpor
pseudotyp
may
due
disrupt
fold
andor
oligomer
along
secretori
pathway
mutat
effect
viru
entri
cell
explor
measur
activ
luciferas
report
gene
figur
mutant
function
exhibit
viru
entri
activ
similar
induc
wildtyp
sarscovpp
albeit
slightli
lower
level
figur
expect
mutant
unabl
enter
cell
figur
cf
empti
vector
observ
correl
absenc
envelop
glycoprotein
incorpor
pseudotyp
effort
directli
demonstr
airway
proteas
mediat
viru
entri
enhanc
due
presenc
cleavag
site
sar
spike
glycoprotein
cell
preincub
wildtyp
sarscovpp
mutant
pseudotyp
ice
allow
viru
attach
entri
unbound
pseudotyp
wash
away
proteas
ad
result
show
wildtyp
mutant
spike
glycoprotein
function
mediat
viru
entri
cell
figur
wherea
airway
proteas
treatment
significantli
increas
entri
sarscovpp
suscept
cell
figur
enhanc
effect
complet
abrog
figur
data
indic
arginin
residu
posit
sensit
airway
proteas
cleavag
turn
significantli
increas
sarscov
infect
airway
proteas
could
cleav
sar
spike
glycoprotein
follow
viruscel
attach
stage
therebi
enhanc
sarscov
entri
human
airway
epitheli
cell
vitro
spike
glycoprotein
mani
envelop
virus
includ
variou
strain
human
influenza
virus
sendai
viru
cleav
hostderiv
proteas
two
noncoval
link
subunit
proteolyt
modif
spike
glycoprotein
major
determin
viru
tropism
pathogen
shown
pneumotrop
virus
whose
infect
determin
airway
proteas
monobas
cleavag
site
identifi
variou
viral
glycoprotein
recogn
proteas
secret
epitheli
cell
data
demonstr
sar
spike
glycoprotein
two
monobas
cleavag
site
suscept
airway
proteas
cleavag
show
specif
airway
proteas
secret
along
respiratori
tract
trypsin
plasmin
recogn
cleav
two
monobas
motif
sar
spike
glycoprotein
furthermor
taken
advantag
flexibl
pseudotyp
particl
investig
molecular
mechan
underli
initi
step
viru
entri
follow
cell
attach
observ
proteas
cleavag
spike
glycoprotein
greatli
enhanc
entri
receptorbind
interact
cell
surfac
observ
suggest
proteolyt
process
bound
spike
result
conform
chang
favor
entri
viru
first
report
demonstr
function
impact
disrupt
cleavag
posit
address
importantli
clarifi
mechan
viru
entri
enhanc
sever
airway
proteas
data
agreement
recent
studi
show
sarscov
smediat
viru
entri
depend
sequenti
proteolyt
cleavag
monobas
site
shown
clinic
observ
sarsinfect
patient
sampl
respiratori
tract
major
cellular
target
infect
replic
similar
coronavirus
sarscov
util
respiratori
gastrointestin
tract
system
primari
entri
site
infect
howev
unexpect
find
sever
studi
indic
human
airway
epitheli
cell
line
nonpermiss
sarscov
found
permiss
sarscov
depend
express
confirm
earlier
studi
identifi
function
cellular
receptor
sarscov
entri
sarscov
also
detect
lung
gastrointestin
tract
kidney
autopsi
sampl
correl
tissu
tropism
pattern
express
human
interestingli
express
epitheli
cell
found
correl
level
cellular
differenti
primari
cell
grown
airliquid
interfac
stimul
cellular
differenti
apic
surfac
express
although
cell
deriv
human
bronchial
epithelium
show
uniqu
morpholog
biochem
characterist
accord
specif
level
cellular
differenti
studi
demonstr
anoth
uniqu
characterist
within
two
cell
line
term
cell
surfac
protein
express
establish
cell
express
normal
cultur
system
vitro
model
sarscov
studi
pseudotyp
virus
use
studi
viru
entri
mechan
cell
tropism
neutral
antibodi
receptor
identif
observ
differenti
virion
incorpor
depend
surfac
express
envelop
glycoprotein
correl
proper
fold
posttransl
modif
envelop
glycoprotein
data
consist
previou
studi
indic
sar
spike
produc
cell
express
highmannos
complexsugar
link
envelop
glycoprotein
show
complexsugar
link
sar
spike
glycoprotein
sole
incorpor
sarscovpp
sar
spike
doubl
mutant
defect
virion
incorpor
like
due
impair
posttransl
modif
envelop
glycoprotein
surprisingli
even
mutant
show
lack
virion
incorpor
postul
defect
case
due
impair
oligomer
envelop
glycoprotein
amino
acid
residu
locat
within
region
sar
spike
glycoprotein
import
trimer
envelop
glycoprotein
format
unpublish
observ
result
mutat
residu
might
gener
local
fold
defect
envelop
glycoprotein
caus
reduc
level
stabl
surfac
express
prevent
effici
incorpor
pseudotyp
separ
studi
recent
demonstr
incorpor
similar
mutant
construct
murin
leukemia
viru
mlv
base
pseudotyp
vector
differ
mutant
envelop
incorpor
respect
studi
might
attribut
greater
hydrophob
substitut
amino
acid
disrupt
oligomer
process
clearli
investig
requir
assess
role
amino
acid
residu
sar
spike
oligomer
previou
studi
demonstr
effect
intracellular
proteas
treatment
eg
cathepsin
l
activ
membran
fusion
properti
sar
spike
exampl
import
role
cleavag
site
shown
artifici
insert
furin
cleavag
site
result
product
cleav
spike
glycoprotein
pseudotyp
allow
infect
cell
presenc
proteas
inhibitor
howev
wildtyp
sar
spike
put
furin
cleavag
motifsit
addit
sarscov
primarili
respiratori
tropism
number
extracellular
proteas
secret
airway
epithelium
therefor
result
suggest
extracellular
airway
proteas
local
along
respiratori
tract
cleav
modifi
wildtyp
sar
spike
earli
stage
viru
entri
viz
viruscel
attach
step
modif
enabl
format
cleav
form
spike
facilit
activ
membran
fusion
subsequ
intracellular
proteas
treatment
remain
possibl
sequenti
activ
extracellular
intracellular
proteas
facilit
sarscov
entri
along
respiratori
tract
anoth
aspect
consid
cleavag
site
describ
report
identifi
use
solubl
spike
protein
conceiv
addit
site
may
involv
upon
receptor
bind
howev
impact
mutat
clearli
indic
function
import
cleavag
posit
viru
entri
one
studi
also
show
effect
larg
concentr
proteas
enhanc
sarscov
infect
cell
howev
data
demonstr
effect
concentr
airway
proteas
induc
sarscov
entri
enhanc
least
less
previous
report
differ
could
due
durat
airway
proteas
treatment
onto
virusadsorb
cell
cleavag
effici
airway
proteas
sensit
detect
system
use
note
found
enhanc
effect
airway
proteas
sarscovpp
entri
strictli
depend
viruscel
attach
step
find
contrast
earlier
studi
done
coronaviru
proteolyt
cleavag
envelop
glycoprotein
virion
surfac
bind
cellular
receptor
necessari
entri
fusion
process
clearli
observ
pretreat
sarscovpp
airway
proteas
dramat
reduc
infect
pseudotyp
particl
wherea
addit
airway
proteas
viruscel
attach
enhanc
viruscel
fusion
postul
receptorbound
spike
glycoprotein
requir
cleavag
mediat
viru
entri
enhanc
spike
glycoprotein
undergo
conform
chang
bind
cellular
receptor
believ
envelop
glycoprotein
undergo
multipl
program
conform
chang
cellular
receptor
interact
process
expos
hydrophob
fusion
peptid
mediat
fusion
viral
envelop
host
cell
membran
shown
howev
entri
sarscovpp
could
still
complet
without
addit
airway
proteas
sever
possibl
could
account
find
first
sarscovpp
could
enter
cell
endosom
pathway
describ
previous
altern
could
partial
switch
spike
glycoprotein
inact
activ
conform
upon
receptor
bind
hypothes
presenc
airway
proteas
cleavag
receptorbound
spike
glycoprotein
might
reduc
threshold
conform
chang
spike
glycoprotein
fusogen
form
thu
facilit
exposur
fusion
peptid
interact
host
cell
membran
current
studi
suggest
sarscov
enter
exit
preferenti
via
apic
surfac
epithelium
coloc
airway
proteas
sarscov
along
respiratori
tract
support
posit
feedback
loop
viru
infect
vivo
conclud
found
cleavag
receptorbound
spike
glycoprotein
airway
proteas
enhanc
vitro
viru
entri
fusion
therefor
identif
reagent
abl
suppress
vivo
activ
airway
proteas
might
provid
addit
antivir
strategi
sarscov
infect
possibl
viral
respiratori
infect
human
influenza
viru
face
current
flu
epidem
threat
cell
line
atcc
cultur
dulbecco
modifi
eagl
medium
supplement
fb
uml
penicillin
streptomycin
transform
human
alveolar
basal
epitheli
atcc
transform
bronchial
epitheli
cell
line
cultur
medium
supplement
fb
lglutamin
antibioticantimycot
transform
bronchial
epitheli
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fb
lglutamin
antibioticantimycot
complet
medium
steril
use
filter
unit
corn
sarscov
spike
cdna
tag
ctermin
peptid
sequenc
sflag
describ
previous
improv
express
yield
codonoptim
sarss
dna
contain
flag
sequenc
fuse
infram
end
produc
use
geneoptim
technolog
geneart
codonoptim
sflag
subclon
express
vector
result
express
plasmid
pcdnasflag
cell
lysat
collect
produc
cell
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
triton
viru
pellet
prepar
ultracentrifug
sucros
cushion
x
g
h
use
beckman
rotor
resuspend
tne
buffer
mm
trishcl
mm
nacl
mm
edta
ph
subject
sdspage
protein
transfer
onto
nitrocellulos
membran
first
incub
block
solut
pb
tween
milk
powder
normal
goat
serum
probe
antiflag
monoclon
antibodi
sigma
detect
antibodi
peroxidaseconjug
goat
antimous
igg
hl
zyme
use
secondari
antibodi
band
visual
xray
film
kodak
use
chemiluminesc
amersham
bioscienc
total
mrna
isol
cell
use
qiagen
rneasi
midi
total
rna
extract
kit
accord
manufactur
instruct
dissolv
rnase
free
cdna
synthes
use
thermoscripttm
rtpcr
kit
specif
primer
forward
primer
ctc
acg
att
gtt
ggg
revers
primer
agc
cac
tcg
cac
atc
amplifi
use
redtaq
dna
polymeras
sigma
quantiti
total
rna
templat
normal
express
forward
primer
cgt
cgt
tcg
aca
acg
gct
revers
primer
aca
tga
tct
ggg
tca
tct
tct
airway
proteas
cleavag
site
mutant
prepar
plasmid
pcdnasflag
stratagen
quikchang
sitedirect
mutagenesi
kit
sitespecif
mutagenesi
carri
singlestep
polymeras
chain
reaction
use
gene
specif
primer
encompass
site
mutat
carri
desir
mutat
nucleotid
methyl
nonmut
parent
dna
templat
remov
dpni
treatment
plasmid
carri
mutat
nucleotid
transform
electropor
posit
clone
carri
mutat
plasmid
screen
digest
mutagen
pcdnasflag
sequenc
uniqu
restrict
enzym
msci
stui
msci
stui
mutat
verifi
dna
sequenc
sar
spike
glycoprotein
trispik
prepar
describ
previous
amount
degre
puriti
recombin
trispik
protein
assess
western
blot
silver
stain
respect
describ
previous
trypsin
purifi
rat
lung
describ
plasmin
purchas
calbiochem
recombin
kindli
provid
dr
noboru
yamaji
masako
kagoshima
astella
pharma
inc
proteas
cleavag
purifi
trispik
protein
perform
treat
trispik
protein
airway
proteas
follow
amino
acid
sequenc
analys
purifi
trispik
protein
first
incub
variou
proteas
includ
trypsin
mgml
plasmin
mgml
equival
mu
proteas
presenc
trishcl
ph
h
purifi
trispik
protein
incub
without
proteas
includ
control
sampl
subject
sdspage
perform
gradient
acrylamid
gel
reduc
condit
accord
method
laemmli
protein
transfer
pvdf
membran
stain
amino
black
cbb
visual
cleavag
product
stain
protein
band
core
analyz
ntermin
amino
acid
sequenc
determin
use
appli
biosystem
gasphas
system
accord
manufactur
instruct
proteas
cleavag
assay
perform
treat
sarscovpp
airway
proteas
infect
step
recombin
sarscovpp
lentivir
vector
express
luciferas
report
gene
produc
cell
describ
previous
use
plasmid
genom
plasmid
pcdnasflag
viru
entri
assay
cell
infect
sarscovpp
cell
seed
onto
plate
cellswel
triplic
cell
seed
onto
plate
cellswel
triplic
follow
day
sarscovpp
ad
well
cell
incub
h
atmospher
complet
medium
ad
well
overnight
incub
medium
renew
h
later
incub
continu
addit
h
cell
wash
lyse
luciferas
activ
measur
microbeta
jet
counter
perkin
elmer
accord
instruct
provid
supplier
promega
test
effect
airway
proteas
treatment
viru
entri
cell
use
model
cell
line
sarscovpp
infect
cell
seed
onto
plate
cellswel
triplic
infect
cell
pretreat
reaction
buffer
dmem
supplement
trishcl
ph
min
ice
sarscovpp
ad
onto
well
incub
cell
anoth
min
ice
mixtur
remov
fresh
reaction
buffer
ad
cell
dilut
airway
proteas
ad
well
incub
min
room
temperatur
mixtur
remov
cell
wash
twice
complet
dmem
medium
incub
overnight
luciferas
activ
measur
perform
describ
result
present
specifi
number
sampl
independ
experi
comparison
two
popul
data
made
use
student
unpair
ttest
confid
limit
signific
set
less
